Shanghai Taichu Biotechnology
A company leading the non-clinical research of new drugs to Contract Development and Manufacturing Organization (CDMO) production
At a glance
- Status
- Operational
- Open positions
- None listed
- Dealroom signal
- 12.3/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, BioTechnology
- Sector
- Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
- Client focus
- B2B
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | May 2023 | $48M | $193M | Apricot Capital · Seasonal investment · Aopeng Investment · IDG Capital | ↗ |
| SEEDEquity / VC | Aug 2022 | $41M | $165M | Lingang Blue Bay Fund | — |
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Shanghai Taichu Biotechnology in its local ecosystem
The Shanghai Taichu Biotechnology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed3 investors entered at this stage
- SISIIC Investment
- TCTaifu Capital
- LFLingang Blue Bay Fund
Series A12 investors entered at this stage
IDG Capital
Apricot Capital- SISeasonal investment
- AIAopeng Investment
Yijing Capital- XCXingzhi Capital
- JCJuntong Capital
SHC Shanghai Biomedical Fund
Boquan Capital- SFShanghai Science and Technology Fund
- LCLula Capital
- ZCZhongxin Capital
Other known investors1 additional known investor
- SIShanghai Institute of Pharmaceutical Industry
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Shanghai Taichu Biotechnology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Shanghai Taichu Biotechnology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









